Sažetak
Uvod. Razlikovanje malignih i inflamatornih procesa još uvek je dijagnostički izazov. Mamografija (MG) i ultrasonografija (US) imaju nisku senzitivnost i specifičnost u gustinom tkiva dojke da bi se mogao prepoznati malignitet. S druge strane, na snimanju magnetnom rezonancom (MRI) lezije maligne mase mogu takođe biti maskirane difuznim inflamatornim procesom. Snimanje pozitronskom emisionom tomografijom pomoću 18-fluorodeoksiglukoze (PDG PET) može biti alternativna metoda koja obećava u proceni sumnjivih masi dojke, posebno kod bolesnica sa pratećim inflamatornim oboljenjima dojke. Prikaz bolesnika. Prikazujemo neobičan slučaj bolesnice sa sumnjivim malignitetom desne dojke na fizikalnom pregledu i radiološkim nalazima koji su išli u prilog mastitisa. Pomoću MS i US nije otkrivena lezija koja bi odgovarala mastitisu. Osim toga, MRI nalazi primarno su bili razmatrani kao infektivni ili granulomatozni mastitis. Međutim, pomoću FDG PET određene su tačne granice tumora i diseminacije karcinoma dojke, sa superiornošću u odnosu na druge, konvencionalne radiološke metode. Zaključak. Ovaj prikaz bolesnika naglašava doprinos FDG PET snimanja ostalim konvencionalnim radiološkim metodama u dijagnostikovanju primarnog tumora, određivanju mesta biopsije i, takođe, gradiranju bolesti, posebno kod bolesnica koje imaju prateće inflamatorno oboljenje dojke.
Ključne reči
Array
Array
Array
Reference
References
Rieber A, Tomczak RJ, Mergo PJ, Wenzel V, Zeitler H, Brambs HJ. MRI of the breast in the differential diagnosis of mastitis versus inflammatory carcinoma and follow-up. J Comput As-sist Tomogr 1997; 21(1): 128–32.
Kocaoglu M, Somuncu I, Ors F, Bulakbasi N, Tayfun C, Ilkbahar S. Imaging Findings in Idiopathic Granulomatous Mastitis. J Comput Assist Tomogr 2004; 28(5): 635–41.
Gunalp B, Ince S, Karacalioglu AO, Ayan A, Emer O, Alagoz E. Clinical impact of (18)F-FDG PET/CT on initial staging and therapy planning for breast cancer. Exp Ther Med 2012; 4(4): 693–8.
Cheng L, Reddy V, Solmos G, Watkins L, Cimbaluk D, Bitterman P, et al. Mastitis, a Radiographic, Clinical, and Histopatholog-ic Review. Breast J 2015; 21(4): 403–9.
Liong YV, Hong GS, Teo JG, Lim GH. Breast ductal carcinoma in situ presenting as recurrent non-puerperal mastitis: Case re-port and literature review. World J Surg Oncol 2013; 11(1): 179.
Uematsu T. MRI findings of inflammatory breast cancer, local-ly advanced breast cancer, and acute mastitis: T2-weighted images can increase the specificity of inflammatory breast can-cer. Breast Cancer 2012; 19(4): 289–94.
Jari I, Naum AG, Ursaru M, Manafu EG, Gheorghe L, Negru D. Breast infections: Diagnosis with ultrasound and mammogra-phy. Rev Med Chir Soc Med Nat Iasi 2015; 119(2): 419–24.
Giess CS, Chikarmane SA, Sippo DA, Birdwell RL. Breast MR Imaging for Equivocal Mammographic Findings: Help or Hin-drance? Radiographics 2016; 36(4): 943–56.
Wang L, Wang D, Fei X, Ruan M, Chai W, Xu L, et al. A rim-enhanced mass with central cystic changes on MR imaging: How to distinguish breast cancer from inflammatory breast diseases? PLoS ONE 2014; 9(3): e90355.
Baslaim MM, Bakheet SM, Bakheet R, Ezzat A, El-Foudeh M, Tulbah A. 18-Fluorodeoxyglucose-positron emission tomogra-phy in inflammatory breast cancer. World J Surg 2003; 27(10): 1099–104.
Hancerliogullari O, Arslan N, Gorgulu S, Can MF, Ayan EH, Ince S, et al. 2-[18f ]-Fluoro-2-deoxy-d-glucose positron emission tomography in the evaluation of breast lesions and axillary in-volvement: A comparison with mammography and histo-pathological diagnosis. Turk J Med Sci 2012; 42(Suppl 1): 1214–21.
Bakheet SM, Powe J, Kandil A, Ezzat A, Rostom A, Amartey J. F-18 FDG uptake in breast infection and inflammation. Clin Nucl Med 2000; 25(2): 100–3.
Alberini J, Lerebours F, Wartski M, Fourme E, Le SE, Gontier E, et al. 18F-fluorodeoxyglucose positron emission tomogra-phy/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer. Cancer 2009; 115(21): 5038–47.